CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company
Corvus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CRVS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464670809
- Phone
- (650) 900-4520
- Business address
- 901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $50,475
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$50,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-12 | Buggy Joseph J EVP Discovery Research | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2018-12-12 | LEA LEIV Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2018-12-12 | Hunt Daniel W. SVP, Chief Business Officer | Grant or award · Stock Option (Right to Buy) | −50,000 | 50,000 | ||
| 2018-12-12 | Verner Erik J. V.P., Chemistry Research | Grant or award · Stock Option (Right to Buy) | −50,000 | 50,000 | ||
| 2018-12-11 | MILLER RICHARD A MD President and CEO | Gift | −10,000 | 1,108,795 | ||
| 2018-12-11 | MILLER RICHARD A MD President and CEO | Gift | −10,000 | 1,098,795 | ||
| 2018-12-06 | MILLER RICHARD A MD President and CEO | Purchase | +5,000 | $5.99 | $30K | 1,118,795 |
| 2018-12-04 | MILLER RICHARD A MD President and CEO | Purchase | +1,502 | $5.95 | $9K | 1,113,795 |
| 2018-06-21 | ADAMS STREET PARTNERS LLC 10% owner | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2018-06-21 | Thompson Peter A. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2018-06-21 | Morrison Scott W Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2018-06-21 | Gould Terry P Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2018-06-21 | CLARK IAN T Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2018-06-21 | Krognes Steve E. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2018-03-12 | Thompson Peter A. Director | Purchase | +588,235 | $8.50 | $5.0M | 5,967,584 |
| 2018-03-12 | ORBIMED ADVISORS LLC Director | Purchase | +588,235 | $8.50 | $5.0M | 5,967,584 |
| 2018-03-12 | Novo Holdings A/S 10% owner | Purchase | +1,176,470 | $8.50 | $10.0M | 4,420,516 |
| 2018-03-12 | ADAMS STREET PARTNERS LLC 10% owner | Purchase | +69,864 | $8.50 | $594K | 69,864 |
| 2018-03-12 | ADAMS STREET PARTNERS LLC 10% owner | Purchase | +236,128 | $8.50 | $2.0M | 236,128 |
| 2018-03-12 | ADAMS STREET PARTNERS LLC 10% owner | Purchase | +67,769 | $8.50 | $576K | 67,769 |
Page 12 of 19 · 371 trades